Skip to main navigation
Vaccitech
  • Home
  • Our Team
    • About
  • Technology
  • Pipeline
  • Partnerships
  • Investors
    • News & Events
    • Stock Information
    • Corporate Governance
    • Financials
    • Investor Resources
  • Careers
  • Contact
Select Page

SEC Filing Details

  • Subscribe
  • RSS Feeds
  • Contact IR
  • Presentations
  • SEC Filings
  • Annual Reports and AGM
  • Quarterly Results
  • SEC Filings
  • Annual Reports and AGM
  • Quarterly Results
SEC Filing Details

SEC Filing

Document Details
Form
8-K/A
Filing Date
May 24, 2022
Document Date
May 12, 2022
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Vaccitech
Issuer
VACCITECH PLC

SEC Filing

Filing Formats
iXBRL
View HTML
Download PDF
Download DOC
Download XLS

SEC Filing

XBRL
XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT

Vaccitech Limited

The Schrödinger Building
Heatley Road
The Oxford Science Park
Oxford
OX4 4GE

T: +44 (0)1865 818808

  • Home
  • About
  • Sitemap
  • Privacy Policy
  • Privacy Notice
  • Careers
  • Contact

Vaccitech is a T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer

  • Twitter
  • LinkedIn
© Vaccitech 2022 All rights reserved.